Actarit

Actarit
Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	None;
Identifiers
	IUPAC name (4-Acetamidophenyl)acetic acid;
CAS Number	18699-02-0 ;
PubChem CID	2018;
ChemSpider	1941 ;
UNII	HW5B6351RZ;
KEGG	D01395 ;
ChEMBL	ChEMBL1226203 ;
CompTox Dashboard (EPA)	DTXSID0020020 ;
ECHA InfoCard	100.038.631
Chemical and physical data
Formula	C10H11NO3
Molar mass	193.202 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(O)Cc1ccc(cc1)NC(=O)C;
	InChI InChI=1S/C10H11NO3/c1-7(12)11-9-4-2-8(3-5-9)6-10(13)14/h2-5H,6H2,1H3,(H,11,12)(H,13,14) ; Key:MROJXXOCABQVEF-UHFFFAOYSA-N ;
(what is this?) (verify)

Actarit is a disease-modifying antirheumatic drug (DMARD) developed in Japan for use in rheumatoid arthritis.[1]

References

Takeba, Y; Suzuki, N; Wakisaka, S; Nagafuchi, H; Mihara, S; Kaneko, A; Asai, T; Sakane, T (Jan 1999). "Effects of actarit on synovial cell functions in patients with rheumatoid arthritis". The Journal of Rheumatology. 26 (1): 25–33. ISSN 0315-162X. PMID 9918236.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.